ABBV vs AMZN: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Amazon.com, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
AbbVie Inc. · Healthcare
$197.69
+6.3% upside to fair value
Grade C
High Quality
VS
Amazon.com, Inc. · Consumer Cyclical
$259.34
+21.8% upside to fair value
Grade B
High Quality
QuantHub Verdict
AMZN has more upside to fair value
(+21.8%).
AMZN trades at a lower forward P/E
(26.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMZN |
| Current Price |
$197.69 |
$259.34 |
| Fair Value Estimate |
$210.22 |
$316.00 |
| Upside to Fair Value |
+6.3%
|
+21.8%
|
| Market Cap |
$349.7B |
$2,789.8B |
| Forward P/E |
83.3x
|
26.5x
|
| EV / EBITDA |
23.4x
|
16.8x
|
| Price / Sales |
5.7x
|
3.9x
|
| Price / FCF |
18.7x
|
—
|
| Revenue Growth YoY |
+10.0%
|
+17.0%
|
| Gross Margin |
70.2%
|
51.8%
|
| Operating Margin |
26.7%
|
13.1%
|
| Return on Equity |
-361.6%
|
21.5%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.35%
|
-0.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology, neuroscience, oncology, and aesthetics. The company benefits from a durable competitive moat driven by blockbuster drugs such as Skyrizi and Rinvoq, which are experiencing rapid growth and offsetting declines from Humira due to biosimilar competition. Despite a high trailing and forwa…
Amazon delivered a landmark Q1 2026 with revenue of $181.5 billion up 17% year over year and diluted EPS of $2.78 versus the $1.63 consensus, driven by AWS reaccelerating to 28% growth, its fastest pace in fifteen quarters, and a record consolidated operating margin of 13.1%. AWS generated $37.6 billion in revenue at a 37.7% segment operating margin, contributing $14.2 billion in operating income…
Accumulation Zones
| Metric |
ABBV |
AMZN |
| Zone Low |
$157.66 |
$237.00 |
| Zone High |
$178.69 |
$268.60 |
| In Buy Zone? |
No
|
Yes
|